Spencer Andrew R, Primbetova Asel, Koppes Abigail N, Koppes Ryan A, Fenniri Hicham, Annabi Nasim
Biomaterials Innovation Research Center, Brigham and Women's Hospital, Harvard Medical School, 65 Landsdowne Street, Boston, Massachusetts 02139, United States.
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
ACS Biomater Sci Eng. 2018 May 14;4(5):1558-1567. doi: 10.1021/acsbiomaterials.8b00135. Epub 2018 Mar 19.
Electroconductive hydrogels are used in a wide range of biomedical applications, including electrodes for patient monitoring and electrotherapy, or as biosensors and electrochemical actuators. Approaches to design electroconductive hydrogels are often met with low biocompatibility and biodegradability, limiting their potential applications as biomaterials. In this study, composite hydrogels were prepared from a conducting polymer complex, poly(3,4-ethylenedioxythiophene):polystyrenesulfonate (PEDOT:PSS) dispersed within a photo-crosslinkable naturally derived hydrogel, gelatin methacryloyl (GelMA). To determine the impact of PEDOT:PSS loading on physical and microstructural properties and cellular responses, the electrical and mechanical properties, electrical properties, and biocompatibility of hydrogels loaded with 0-0.3% (w/v) PEDOT:PSS were evaluated and compared to GelMA control. Our results indicated that the properties of the hydrogels, such as mechanics, degradation, and swelling, could be tuned by changing the concentration of PEDOT:PSS. In particular, the impedance of hydrogels decreased from 449.0 kOhm for control GelMA to 281.2 and 261.0 kOhm for hydrogels containing 0.1% (w/v) and 0.3% (w/v) PEDOT:PSS at 1 Hz frequency, respectively. In addition, an experiment demonstrated that the threshold voltage to stimulate contraction in explanted abdominal tissue connected by the composite hydrogels decreased from 9.3 ± 1.2 V for GelMA to 6.7 ± 1.5 V and 4.0 ± 1.0 V for hydrogels containing 0.1% (w/v) and 0.3% (w/v) PEDOT:PSS, respectively. studies showed that composite hydrogels containing 0.1% (w/v) PEDOT:PSS supported the viability and spreading of C2C12 myoblasts, comparable to GelMA controls. These results indicate the potential of our composite hydrogel as an electroconductive biomaterial.
导电水凝胶被广泛应用于各种生物医学领域,包括用于患者监测和电疗的电极,或用作生物传感器和电化学致动器。设计导电水凝胶的方法常常面临生物相容性和生物降解性较低的问题,这限制了它们作为生物材料的潜在应用。在本研究中,复合水凝胶由一种导电聚合物复合物制备而成,即聚(3,4-乙撑二氧噻吩):聚苯乙烯磺酸盐(PEDOT:PSS)分散在可光交联的天然衍生水凝胶甲基丙烯酰化明胶(GelMA)中。为了确定PEDOT:PSS负载量对物理和微观结构性质以及细胞反应的影响,对负载0-0.3%(w/v)PEDOT:PSS的水凝胶的电学和力学性能、电学性质以及生物相容性进行了评估,并与GelMA对照进行了比较。我们的结果表明,水凝胶的性质,如力学性能、降解和溶胀,可以通过改变PEDOT:PSS的浓度来调节。特别是,在1Hz频率下,水凝胶的阻抗从对照GelMA的449.0kΩ分别降至含有0.1%(w/v)和0.3%(w/v)PEDOT:PSS的水凝胶的281.2kΩ和261.0kΩ。此外,一项实验表明,通过复合水凝胶连接的离体腹部组织中刺激收缩的阈值电压从GelMA的9.3±1.2V分别降至含有0.1%(w/v)和0.3%(w/v)PEDOT:PSS的水凝胶的6.7±1.5V和4.0±1.0V。研究表明,含有0.1%(w/v)PEDOT:PSS的复合水凝胶支持C2C12成肌细胞的活力和铺展,与GelMA对照相当。这些结果表明我们的复合水凝胶作为导电生物材料的潜力。